This narrative overview of stroke epidemiology shows dramatic changes in stroke incidence, prevalence, mortality, disability, and the understanding of risk factors and primary stroke prevention strategies over the last few decades. Likely future directions of stroke epidemiology and prevention are outlined.
RomeroJRWolfPA. Epidemiology of Stroke: legacy of the Framingham Heart Study. Glob Heart2013; 8: 67–75.
2.
WhisnantJPMulderDW. Leonard T. Kurland: 1921–2001. Ann Neurol2002; 55: 663.
3.
AhoKHarmsenPHatanoSMarquardsenJSmirnovVEStrasserT. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ1980; 58: 113–130.
4.
Tunstall-PedoeH. Monitoring trends in cardiovascular disease and risk factors: the WHO “Monica” project. WHO Chronicle1985; 39: 3–5.
5.
StegmayrBAsplundKKuulasmaaKRajakangasAMThorvaldsenPTuomilehtoJ. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. Stroke1997; 28: 1367–1374.
6.
SudlowCLWarlowCP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke1997; 28: 491–499.
7.
MalmgrenRWarlowCBamfordJSandercockP. Geographical and secular trends in stroke incidence. Lancet1987; 2: 1196–1200.
8.
SudlowCLMWarlowCP. Comparing Stroke incidence worldwide: what makes studies comparable?Stroke1996; 27: 550–558.
9.
FeiginVHoornSV. How to study stroke incidence. Lancet2004; 363: 1920.
10.
FeiginVL. Stroke in developing countries: can the epidemic be stopped and outcomes improved?Lancet Neurol2007; 6: 94–97.
11.
FeiginVLLawesCMBennettDABarker-ColloSLParagV. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol2009; 8: 355–369.
12.
ThriftAGThayabaranathanTHowardGet al.Global stroke statistics. Int J Stroke2017; 12: 13–32.
13.
GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol2017; 16: 877–897.
14.
Institute for Health Metrics and Evaluation (IHME). Global Health Data Exchange. Seattle, WA: IHME, University of Washington, 2016, http://ghdx.healthdata.org (accessed 5 March 2018).
15.
RothwellPMCoullAJSilverLEet al.Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet2005; 366: 1773–1783.
16.
SeshadriSBeiserAKelly-HayesMet al.The lifetime risk of stroke: estimates from the Framingham Study. Stroke2006; 37: 345–350.
17.
SeshadriSWolfPA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol2007; 6: 1106–1114.
18.
BerryJDDyerACaiXet al.Lifetime risks of cardiovascular disease. New Engl J Med2012; 366: 321–329.
19.
TurinTCKokuboYMurakamiYet al.Lifetime risk of stroke in Japan. Stroke2010; 41: 1552–1554.
20.
TakahashiIGeyerSMNishiNet al.Lifetime risk of stroke and impact of hypertension: estimates from the adult health study in Hiroshima and Nagasaki. Hypertens Res2011; 34: 649–654.
21.
TurinTCOkamuraTAfzalARet al.Hypertension and lifetime risk of stroke. J Hypertension2016; 34: 116–122.
22.
WangYLiuJWangWet al.Lifetime risk of stroke in young-aged and middle-aged Chinese population: the Chinese Multi-Provincial Cohort Study. J Hypertension2016; 34: 2434–2440.
23.
LeeningMJGFerketBSSteyerbergEWet al.Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ2014; 349: g5992.
24.
FeiginVLNguyenGCercyKet al.Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med2018; 379: 2429–2437.
25.
FeiginVLRothGANaghaviMet al.Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global burden of disease study 2013. Lancet Neurol2016; 15: 913–924.
26.
O’DonnellMJChinSLRangarajanSet al.Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet2016; 388: 761–775.
27.
United Nations General Assembly. Resolution adopted by the General Assembly: 66/2: political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases. Adopted September 19, 2011, Published January 24, 2012 ed2012.
28.
World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. WHO, Geneva, wwwwhoint/nmh/events/ncd_action_plan/en/ (2013, accessed 10 February 2018).
RoseG. Strategy of prevention: lessons from cardiovascular disease. BrMed J Clin Res1981; 282: 1847–1851.
31.
From Burden to “Best Buys”: reducing the Economic impact of non-communicable diseases in low- and middle-income countries. World Health Organization, World Economic Forum and the Harvard School of Public Health. World Economic Forum, Geneva, Switzerland 2011, www.who.int/nmh/publications/best_buys_summary.pdf (accessed 11 September 2018).
32.
EagleKAGinsburgGSMusunuruKet al.Identifying patients at high risk of a cardiovascular event in the near future. Circulation2010; 121: 1447–1454.
33.
EmbersonJWhincupPMorrisRWalkerMEbrahimS. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J2004; 25: 484–491.
34.
BrindlePEmbersonJLampeFet al.Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. Br Med J2003; 327: 1267–1270.
35.
DaltonARHSoljakMSamarasunderaEMillettCMajeedA. Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme. Eur J Prevent Cardiol2013; 20: 142–150.
36.
KrogsbøllLTJørgensenKJGrønhøj LarsenCGøtzschePC. General health checks in adults for reducing morbidity and mortality from disease: cochrane systematic review and meta-analysis. BMJ2012; 345: e7191.
37.
JørgensenTJacobsenRKToftUAadahlMGlümerCPisingerC. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: inter99 randomised trial. BMJ2014; 348: g3617.
38.
CapewellS. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ2008; 337: a1395.
FeiginVLNorrvingBGeorgeMGFoltzJLRothGAMensahGA. Prevention of stroke: a strategic global imperative. Nat Rev Neurol2016; 12: 501–512.
42.
FeiginVLKrishnamurthiRBhattacharjeeRet al.New strategy to reduce the global burden of stroke. Stroke2015; 46: 1740–1747.
43.
FeiginVLNorrvingBMensahGA. Primary prevention of cardiovascular disease through population-wide motivational strategies: insights from using smartphones in stroke prevention. BMJ Global Health2017; 2: e000306doi: 10.1136/bmjgh-2017-000306. eCollection 2016.
44.
FeiginVLNorrvingB. A new paradigm for primary prevention strategy in people with elevated risk of stroke. International J Stroke2014; 9: 624–626.
45.
ParmarPKrishnamurthiRIkramMAet al.The stroke riskometer(TM) app: validation of a data collection tool and stroke risk predictor. Int J Stroke2015; 10: 231–244.
46.
PuskaP. Successful prevention of non-communicable diseases: 25 year experiences with North Karelia project in Finland. Pub Health Med2002; 4: 5–7.
47.
MorganJ. The power of the app: can mobile-technology save lives?Lancet Neurol2016; 15: P668.
48.
Krishnamurthi R, Bhattacharjee R, Parmar P, et al. Effectiveness of the stroke riskometer app for primary stroke prevention: a pilot RCT. Final Program of the International Stroke Conference in Los Angeles, USA 23-26 January 2018. Late-Breaking News Science Abstracts of of the International Stroke Conference 24 January 2018 2018;Presentation Number LBP18:p. 85.
49.
KrishnamurthiRHaleLBarker-CollloSet al.Mobile technology for primary stroke prevention: a proof-of-concept pilot randomised controlled trial – a brief report. Stroke2018; 50: 196–198.
50.
KulshreshthaAVaccarinoVJuddSEet al.Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke2013; 44: 1909–1914.
51.
FolsomARYatsuyaHNettletonJALutseyPLCushmanMRosamondWD. Community prevalence of ideal cardiovascular health, by the american heart association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol2011; 57: 1690–1696.
52.
Martins SC, Sacks C, Hacke W, Brainin M, Figueiredo FDA and Pontes-Neto O. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol 2019; (accepted for publication).
53.
JohnsonWOnumaOOwolabiMSachdevS. Stroke: a global response is needed. Bull World Health Organ2016; 94: 634–634a.
54.
LindsayPFurieKLDavisSMDonnanGANorrvingB. World stroke organization global stroke services guidelines and action plan. Int J Stroke2014; 9: 4–13.
55.
BraininM. Stroke units around the world: the success story continues. Lancet2018; 391: 1970–1971.
56.
BraininMFeiginVMartinsSet al.Cut stroke in half: polypill for primary prevention in stroke. Int J Stroke2018; 13: 633–647.
57.
NorrvingBBarrickJDavalosAet al.Action Plan for stroke in Europe 2018–2030. Eur Stroke J2018; 3: 309–336.
58.
OwolabiMJohnsonWKhanTFeiginV. Effectively combating stroke in low- and middle-income countries: placing proof in pragmatism – the lancet neurology commission. J Stroke Med2018; 1: 65–67.
59.
DubeyDAmritphaleASawhneyAAmritphaleNDubeyPPandeyA. Smart phone applications as a source of information on stroke. J Stroke2014; 16: 86–90.
60.
FeiginVNorrvingBSudlowCLMSaccoRL. Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke2018; 49: 2248–2255.
61.
FeiginVLHowardG. The importance of epidemiological studies should not be downplayed. Stroke2008; 39: 1–2.
62.
St SauverJLGrossardtBRYawnBPet al.Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol2012; 41: 1614–1624.
63.
SöderholmAStegmayrBGladerELAsplundK. Validation of hospital performance measures of acute stroke care quality. Riksstroke, the Swedish Stroke Register. Neuroepidemiology2016; 46: 229–234.
64.
BarberPAKrishnamurthiRParagVet al.Incidence of transient ischemic attack in Auckland, New Zealand, in 2011 to 2012. Stroke2016; 47: 2183–2188.
65.
KleindorferDPanagosPPancioliAet al.Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke2005; 36: 720–723.
66.
CancelliIJanesFGigliGLet al.Incidence of transient ischemic attack and early stroke risk: validation of the ABCD2 score in an Italian population-based study. Stroke2011; 42: 2751–2757.
67.
GilesMFRothwellPM. Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing2007; 36: 676–680.
BohenskyMAJolleyDSundararajanVet al.Data Linkage: a powerful research tool with potential problems. BMC Health Serv Res2010; 10: 346doi: 10.1186/1472-6963-10-346.
70.
ParkeHLEpiphaniouEPearceGet al.Self-management support interventions for stroke survivors: a systematic meta-review. PLoS One2015; 10: e0131448.
71.
JonesKMBhattacharjeeRKrishnamurthiRet al.Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: a randomized controlled pilot study. Clin Rehabil2018; 32: 1086–1097.